Tower Research Capital LLC (Trc) Axonics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Axonics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,437 shares of AXNX stock, worth $243,958. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,437

Previous 9,203 62.65%

Holding current value

$243,958

Previous $618,000 61.33%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $388,051 - $401,717	-5,766 Reduced 62.65%	3,437 $239,000
Q2 2024 Aug 13, 2024	BUY	$66.47 - $69.65 $581,280 - $609,089	8,745 Added 1909.39%	9,203 $618,000
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $709,791 - $868,734	-12,525 Reduced 96.47%	458 $31,000
Q4 2023 Feb 13, 2024	BUY	$49.38 - $63.75 $480,418 - $620,223	9,729 Added 298.99%	12,983 $807,000
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $69,457 - $89,264	1,428 Added 78.2%	3,254 $182,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $43,095 - $54,068	898 Added 96.77%	1,826 $92,000
Q1 2023 May 09, 2023	BUY	$52.6 - $67.34 $30,928 - $39,595	588 Added 172.94%	928 $50,000
Q4 2022 Feb 10, 2023	SELL	$59.56 - $76.6 $193,153 - $248,413	-3,243 Reduced 90.51%	340 $21,000
Q3 2022 Nov 10, 2022	SELL	$57.96 - $78.12 $279,251 - $376,382	-4,818 Reduced 57.35%	3,583 $253,000
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $315,644 - $514,780	7,991 Added 1949.02%	8,401 $476,000
Q1 2022 May 12, 2022	SELL	$43.74 - $62.76 $6,386 - $9,162	-146 Reduced 26.26%	410 $26,000
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $190,638 - $279,610	-3,812 Reduced 87.27%	556 $32,000
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $102,847 - $136,632	-1,737 Reduced 28.45%	4,368 $284,000
Q2 2021 Aug 16, 2021	BUY	$51.39 - $66.9 $184,490 - $240,171	3,590 Added 142.74%	6,105 $387,000
Q1 2021 May 17, 2021	BUY	$49.14 - $59.89 $58,820 - $71,688	1,197 Added 90.82%	2,515 $150,000
Q4 2020 Feb 16, 2021	SELL	$42.19 - $51.5 $502,187 - $613,004	-11,903 Reduced 90.03%	1,318 $66,000
Q3 2020 Nov 16, 2020	BUY	$35.33 - $51.04 $388,418 - $561,133	10,994 Added 493.67%	13,221 $675,000
Q2 2020 Aug 13, 2020	BUY	$22.91 - $39.83 $51,020 - $88,701	2,227 New	2,227 $78,000
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $15,864 - $36,409	-965 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$19.57 - $28.96 $1,350 - $1,998	69 Added 7.7%	965 $27,000
Q3 2019 Nov 05, 2019	BUY	$26.92 - $42.41 $24,120 - $37,999	896 New	896 $24,000
Q1 2019 May 14, 2019	SELL	$13.32 - $24.35 $48,471 - $88,609	-3,639 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $48,034 - $59,788	3,639 New	3,639 $55,000

Others Institutions Holding AXNX

# of Institutions

234

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Axonics, Inc. Transaction History